Insmed to Host First-Quarter 2025 Financial Results Conference Call on Thursday, May 8, 2025 | INSM Stock News

2 days ago

Insmed (INSM, Financial) to release Q1 2025 financial results on May 8, 2025.
Conference call scheduled for 8:00 a.m. ET, accessible via phone or webcast.
Replay available until May 15, 2025, with a 90-day archived webcast.

Insmed Incorporated (INSM), a biopharmaceutical company based in Bridgewater, New Jersey, has announced the release of its first-quarter 2025 financial results scheduled for Thursday, May 8, 2025. This will be followed by a conference call at 8:00 a.m. ET, where the company's management will discuss the financial outcomes and provide an update on business developments.

Investors and other interested parties can participate in the conference call by dialing (888) 210-2654 for U.S. callers or (646) 960-0278 for international participants, using the access code 7862189. Additionally, the call will be webcast live on Insmed's official website at www.insmed.com.

A replay of the conference call will be accessible approximately one hour after its conclusion and will remain available until May 15, 2025. The replay can be accessed by dialing (800) 770-2030 in the U.S. or (609) 800-9909 internationally, also using the access code 7862189. Furthermore, the webcast will be archived for a 90-day period under the Investor Relations section of the company's website.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.